glp-1 and blood pressure medication drugs improve liver heart health GLP-1 Agonists - FAQ —

Preclinical studies have confirmed that GIPRGLP1R coagonists improve several hallmarks of metabolic syndrome, such as obesity, hyperglycemia, and dyslipidemia

On March 20, 2026, Chinas patent on semaglutide (the active ingredient in Ozempic and Wegovy) expiresyears ahead of patent expirations in the U.

However, it...

But if you actually read the methodology, you realize we are being sold an illusion

While GLP-1 agonist therapy medications have been marketed as diabetes treatments before, Mounjaro also has the action of glucose-dependent insulinotropic polypeptide (GIP)

Compounded Tirzepatide, Semaglutide, and Bioidentical HRT Telehealth Plans Through Gala GLP-1: Licensed Providers, $149/Mo Pricing, and All-50-States Access Explained for 2026